Business Wire

Netceed Strengthens Board with Global Infrastructure and Technology Leaders

1.4.2026 15:00:00 EEST | Business Wire | Press release

Share

Netceed, a global leader in delivering supply chain solutions across broadband, data center and energy infrastructure, today announced the appointment of Franck Bruel, Jan Frykhammar and Stacey Thompson to advise as strategic advisors to its Board of Directors.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260401045867/en/

Franck Bruel

Following the recently announced recapitalization of the Netceed Group and under the chairmanship of Rajeev Suri, the company is strengthening its Board with globally recognized leaders across telecommunications infrastructure, industrial distribution, energy infrastructure and hyperscale technology.

Collectively, the new appointees bring decades of leadership experience across some of the world’s most influential infrastructure and technology companies, reflecting Netceed’s ambition to play a leading role in the next generation of global digital, AI and energy infrastructure.

Rajeev Suri, Chairman of Netceed, said:

“Netceed sits at the intersection of several powerful infrastructure trends, from broadband expansion to AI-driven data infrastructure and energy networks. As the company enters its next phase of growth, it is important that Netceed benefits from deep operational experience across these sectors.

Franck, Jan and Stacey bring significant experience across global infrastructure, telecommunications and industrial distribution. Their perspectives, spanning international industry leadership, financial governance and large-scale network deployment, will strengthen Netceed as it continues to expand globally.”

Alper Turken, CEO of Netceed, said:

“We are delighted to welcome Franck, Jan and Stacey and look forward to benefiting from their experience as we continue to scale Netceed globally. I am excited to collaborate with such a distinguished group of industry leaders as we execute our vision of building Netceed into a global leader in infrastructure-centric supply chain solutions.”

Appointments

Franck Bruel is a global infrastructure and professional distribution executive with more than three decades of leadership experience across energy services and electrical and technical distribution. He has been a member of the ENGIE Group Executive Committee, overseeing major international businesses across Europe and the Americas in sustainable energy infrastructure and technical services. Earlier in his career, he served as CEO of Sonepar, the global leader in electrical equipment distribution.

Jan Frykhammar is a senior telecommunications and technology executive with extensive global leadership experience in finance, operations and corporate governance. He spent nearly three decades at Ericsson, where he served as Group CFO and later interim President and CEO, leading the company during a period of strategic transition in the global telecommunications industry. He currently serves on several international boards across telecommunications and technology sectors.

Stacey Thompson is a technology infrastructure executive with deep operational experience in network deployment and large-scale infrastructure programs. She currently serves as Chief Executive Officer of ADB Companies, a leading provider of building infrastructure to drive future connectivity supporting broadband, wireless and data center networks. Prior to joining ADB in 2022 as Chief Operating Officer, she spent more than 26 years at AT&T, where she led major broadband, wireless and fiber deployment initiatives across the United States.

About Netceed

Netceed is a global infrastructure supply chain solutions provider enabling the critical networks modern society depends on. With global scale and local expertise, Netceed delivers end-to-end supply chain services and integrated solutions across broadband, AI infrastructure and energy networks. From planning and sourcing through pre-integrated deployments—including pre-terminated PoPs, integrated active cabinets and automated street cabinets—Netceed helps customers reduce risk, accelerate builds and operate networks at scale, serving more than 19,000 customers worldwide.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260401045867/en/

Contacts

Company Contact
Brian Hawe, Chief Marketing Officer, +1 848-319-4303, press@netceed.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 12:47:00 EEST | Press release

Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye